1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Orthotics and Prosthetics Outcomes Research Program (OPORP) is sponsored by Department of Defense (DoD) - Defense Health Agency Contracting Activity (DHACA). The OPORP aims to advance orthotic and prosthetic research to optimize evidence-based care and clinical outcomes for Service Members, Veterans, and persons with limb loss and limb impairment. This includes research on existing devices and rehabilitation strategies.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Orthotics and Prosthetics Outcomes Research Program, Congressionally Directed Medical Research Programs You are using an outdated browser. Please upgrade your browser to improve your experience. U.S. Department of War organization.
Due to routine system maintenance the CDMRP website will be unavailable from COB 24 April - 27 April COB.
DEPARTMENT OF WAR - CONGRESSIONALLY DIRECTED MEDICAL RESEARCH PROGRAMS Transforming Health Care through Innovative and Impactful Research Orthotics and Prosthetics Outcomes Orthotics and Prosthetics Outcomes Vision – To attain the highest possible quality of life for individuals with limb loss and limb impairment Mission – Advance orthotic and prosthetic research to optimize care and clinical outcomes for Service Members, Veterans, and persons with limb loss and limb impairment Recent advancements in commercially available orthotic and prosthetic devices have dramatically improved device capability, regardless of the underlying condition which resulted in the limb loss or limb impairment.
However, there remains a need for evaluation of devices and treatments to identify those that provide the most improvement in user functionality and quality of life for our Service Members, Veterans, and all persons living with limb loss or limb impairment.
The Orthotics and Prosthetics Outcomes Research Program, OPORP, was established by Congress in fiscal year 2014 to enhance the lives of Service Members, Veterans, and others with limb loss or limb impairment by improving the outcomes of orthotic and prosthetic device implementation. This includes improving the ability to carry out daily activities, enhancing work productivity, and increasing the possibility of returning to duty/work.
The OPORP supports research on outcomes-based best practices through analysis of prosthetic and/or orthotic device options that are currently clinically available, and not on the development of new technology or the improvement of an existing technology. Development and employment of new approaches and tools for measuring outcomes is allowed.
The goal of the OPORP is to improve our understanding and ultimately advance the implementation of the most effective prescriptions for prosthetic and orthotic devices, treatment, rehabilitation, and secondary health effect prevention options for patients, clinicians, other caregivers, and policymakers.
Congressional Appropriations Recent Applications Recommended for Funding FY23 Peer Review Participants Orthotics and Prosthetics Outcomes Research Program Booklet Phil Skiff: Hope Through Advocacy After a Improved Daily Comfort and Mobility for Lower-Limb Amputees Using Novel Release-Relock System Dr. Susannah Engdahl: Three Perspectives in One Hip Muscle Quality and Osseointegration Outcomes Sweaty Issues: Seeking to Reduce Residual Limb Perspiration to Improve the Quality of Life of Amputees Improving the Control of Powered Lower Limb Prostheses Ruggedized Odyssey Ankle (ROA) Sarah Keitt: Feeling Empowered Improving the Control of Powered Lower Limb Prostheses Ruggedized Odyssey Ankle (ROA) Click here to provide feedback/comments to the OPORP Last updated Monday, June 29, 2026
According to the current listing, eligibility includes: Unrestricted (i. e. , open to any type of entity), with multidisciplinary collaborations encouraged among academia, industry, patient advocacy, the military Services, the U. Confirm the full requirements in the official notice before applying.
Orthotics and Prosthetics Outcomes Research Program (OPORP) is funded by Department of Defense (DoD) - Defense Health Agency Contracting Activity (DHACA). Verify program details on the funder's official page before applying.
Yes — this listing is flagged as national in scope, so applicants across the U.S. may apply, subject to the sponsor's other eligibility criteria.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Trauma Immunology Research Award (TIRA) is sponsored by Department of Defense (DoD) - Defense Health Agency Contracting Activity (DHACA). Supports basic and applied research and early-stage development of materiel and knowledge products to address critical gaps in the understanding of the immune system, immune response, immune function, and other associated host responses in combat injuries, particularly severe po…
DoD Rare Cancers, Idea Development Award (FY24 RCRP) is sponsored by Department of Defense (DoD) - Defense Health Agency Contracting Activity (DHACA). This award promotes new ideas in rare cancers that are in early stages of development and have the potential to yield impactful data and new avenues of investigation. It supports research with preliminary data that could lead to critical discoveries or major advancements.
CDMRP's FY26 portfolio funds 34 programs, and October 2026 is dense with full-application deadlines: PRCRP October 5, PCRP October 7, MRP October 14. Every one of them is gated behind a pre-application that closed months earlier. Here is what that two-step structure actually costs applicants, and how to be inside the gate for FY27.
Read articleThe Department's FY26 SBIR/STTR Release 3 opened June 24 with roughly 37 topics across DARPA, the Navy, the Air Force, and the defense components, all closing July 22. The compressed four-week window is unforgiving, but the bigger mistake founders make is treating every component the same. Here is how to read the release, the eligibility rules that disqualify good companies, and why the component you target matters more than the topic you pick.
Read articleDoW's 2026 SBIR Broad Agency Announcement now operates on a monthly pre-release / quarterly close cadence. The 42 topics closing June 24 are the first test of whether the new rhythm produces the steady-state deal flow defense innovators have been asking for since 2022.
Read article